FDA Clears Eliglustat (Cerdelga) for Gaucher DiseaseFDA Clears Eliglustat (Cerdelga) for Gaucher Disease

The new drug proved as effective as enzyme replacement therapy in treating the rare genetic disease in a clinical trial. FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news